ACSL4 and lung carcinoma: The prognostic analysis indicated that the colorectal patient with higher ACSL4 expression had poor survival; in contrast, the brain, breast, and lung cancer patient with lower ACSL4 expression had poor survival (Fig 5B and S6 Table).